当前位置: X-MOL 学术Ann. Hematol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion.
Annals of Hematology ( IF 3.5 ) Pub Date : 2020-01-01 , DOI: 10.1007/s00277-019-03874-w
Sophie Park 1 , Charikleia Kelaidi 2 , Mathieu Meunier 1 , Nicole Casadevall 3 , Aaron T Gerds 4 , Uwe Platzbecker 5
Affiliation  

This article was originally published without an Open Access but due to the authors final decision to opt for Open Choice this correction was created.

中文翻译:

校正至:血清促红细胞生成素在低危骨髓增生异常综合症患者中的预后价值:文献复习和专家意见。

本文最初是在没有开放访问的情况下发布的,但是由于作者最终决定选择“开放选择”,因此创建了此更正。
更新日期:2020-01-06
down
wechat
bug